Non-Invasive Biomarkers of NASH

The following publication discusses the latest research regarding the Non-Invasive Biomarkers of Nonalcoholic Steatohepatitis (NASH).  Nature Medicine originally published this article, coauthored by ERG’s Vice President of Clinical Pharmacology Services Clay Dehn, on February 10th, 2022. This browser does not support PDFs. Please download the PDF to view it: Download PDF.

STUDIES ARE ENROLLING NOW!

Normal Healthy Volunteers

We are now searching for healthy adults to participate in upcoming clinical trials. Learn more about how to get involved today!

Depression

If you or someone you know is affected by MDD, upcoming clinical trials may be an option. Learn more today!

Bipolar Disorder

Living with Bipolar Disorder? A Clinical Trial May Be An Option. Learn more today!

Obesity

If you or someone you know is diagnosed with Obesity, you may qualify for a clinical trial. Learn more about today.